CHICAGO EQUITY PARTNERS LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 188 filers reported holding REPLIGEN CORP in Q4 2017. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2019$2,896,000
+73.5%
33,695
+19.3%
0.13%
+101.6%
Q1 2019$1,669,000
+49.0%
28,250
-3.3%
0.06%
+82.9%
Q3 2017$1,120,000
+169.9%
29,215
+112.5%
0.04%
+218.2%
Q3 2016$415,00013,7500.01%
Other shareholders
REPLIGEN CORP shareholders Q4 2017
NameSharesValueWeighting ↓
Conestoga Capital Advisors, LLC 1,291,805$53,532,0002.79%
Ranger Investment Management 919,366$38,099,0002.72%
Monashee Investment Management LLC 100,000$4,144,0001.75%
Lisanti Capital Growth, LLC 49,450$2,049,0001.36%
Pier Capital, LLC 175,565$7,275,0001.26%
SANDLER CAPITAL MANAGEMENT 221,070$9,161,0000.99%
PALISADE CAPITAL MANAGEMENT, LP 630,333$26,121,0000.98%
AWM Investment Company, Inc. 120,000$4,973,0000.88%
Stephens Investment Management Group LLC 857,714$35,544,0000.86%
Summit Creek Advisors LLC 79,066$3,276,0000.68%
View complete list of REPLIGEN CORP shareholders